An Interview with Veranova’s CEO, Mike Riley

Mike Riley sat down with PharmTech at CPHI Milan to discuss the company’s next phase of growth.

Mike talks about how customer expectations are changing as drug pipelines move toward more complex modalities such as ADCs, HPAPIs, PROTACs, peptides and oligonucleotides. He also covers Veranova’s investments in highly potent API capabilities, new approaches to peptide manufacturing, and the growing focus on supply chain resilience and US-based production.

Watch the video to hear Mike’s thoughts on what sets Veranova apart in this fast-changing market.

Watch video on YouTube
PharmTech interview behind the scenes.

Veranova is your next great decision

Discover new ways to advance your science with Veranova.

Contact us